Josh Welle

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: Africa

Consulting Services

Research Consulting Grant Submission

Areas Of Interest

Syntaxin 5 Protein Associated Antigens, HIV SAP Kinase 2 Hyperprolactinemias Personnel Discipline On-Line Systems Gynecologic Neoplasms Hydrogen-1 Micro Insurance, Health Cells, Plasma Strengthening Program, Weight-Lifting NKG2A Receptor Kallmanns Syndrome Nuclear Power Plants Megaloblastic Anemia Urethral Slings, Male Ipratropium Bromide, (exo,syn)-Isomer Surgical Procedures, Dermatologic Thyroiditis, Acute Infectious Interdigitating Cells Vasorelaxation Tendonitis Plant, Eremophila Atypical Mycobacteriosis, Familial Biomimetic Devices Groundwater Calorimetric Differential Thermal Analysis Dyssynergia Cerebellaris Progressiva Intellectually Disabled Educations Theory, Psychological Ventricle, Complex Single rhoGDI gamma Healthy Participants Activins Cross-Neutralizing Antibodies Pigtail Monkey Inflammatory Myelopathy Antigen, CD 120a Stabilizing Factor, Fibrin

Professional Narrative

Dr. Josh Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Senior Director, Mayo Clinic 2009
Medical Writer, Harvard Med 1998

Education

Doctor of osteopathic medicine, Weill Medical College 2007
Master of Science in physician assistant, Yale School of Medicine 2003

Referees

Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02